That selectivity is scientifically valuable: when investigators want to isolate GLP-1-driven signalling from other incretin inputs, semaglutide is the cleaner tool
Emailed about an older lot certificate and support sent the full PDF the same afternoon
Switching or combining these medicines should only be considered with qualified clinical oversight
Improves Glycemic Control: In persons with type 2 diabetes, retatrutide lowers HbA1c and fasting glucose levels, with efficacy sometimes exceeding established glucose-lowering medications 1,2
At Independent Wellness, patients work with Bonnie Lea Davis, FNP-C, for ongoing support and continuity of care
Retatrutide is an unlicensed investigational tri-agonist (GLP-1, GIP, glucagon) with no MHRA or EMA marketing authorisation as of 2024